InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Insider track record
CFODisclosed buys
0
Disclosed sells
1
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the detailed record of transactions filed by Farrow Jeffrey S, Chief Financial Officer. Director active across 2 companies, notably Global Blood Therapeutics, Inc.. In total, 16 filings have been published. Split: 0 buy · 1 sell. Total volume traded: €54k. History available since 27 September 2022. The latest transaction was disclosed on 18 March 2025 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations16 total
1,284 shares@ US$46.29100.0% of flowCommon StockSEC:0001819790-25-000054:0
8,019 sharesCommon StockSEC:0001819790-25-000047:0
27,881 sharesCommon StockSEC:0001819790-24-000089:0
26,739 sharesCommon StockSEC:0000899243-22-033145:0
23,653 shares@ US$16.40100.0% of flowCommon StockSEC:0000899243-22-032265:0
2,763 sharesCommon StockSEC:0000899243-22-030475:0
6,145 sharesCommon StockSEC:0000899243-22-027634:0
2,763 sharesCommon StockSEC:0000899243-22-009239:0
9,020 sharesCommon StockSEC:0000899243-22-004639:0
9,020 sharesCommon StockSEC:0000899243-22-004639
9,020 sharesCommon StockSEC:0000899243-21-037668
9,020 sharesCommon StockSEC:0000899243-21-037668:0
2,762 sharesCommon StockSEC:0000899243-21-035221:0
2,762 sharesCommon StockSEC:0000899243-21-035221
9,020 sharesCommon StockSEC:0000899243-21-031353
9,020 sharesCommon StockSEC:0000899243-21-031353:0
16 of 16 declarations
About Farrow Jeffrey S
Jeffrey S. Farrow is the Chief Financial Officer of Global Blood Therapeutics, Inc. In this role, he oversees the financial management of the company, including financial planning, risk management, and financial reporting. Farrow plays a crucial role in the company's financial strategy, contributing to informed decision-making to support growth and profitability. His experience in finance is a valuable asset to the organization.
